THE LIVER – AN UPDATE
Keywords:
liver disorder/Classification, hepatitis, liver disorders/dental care
Abstract
Dental practitioners are increasingly exposed to patients with medical problems these days. The liver disorder is one such group of disease which is associated with profound morbidity. There have been instances of neglect leading to transmission of infections in dental settings. It has also been observed that there are instances where dentists refuse to treat patients with certain illnesses due to ignorance of facts. It is mandatory for us to update our knowledge regularly. In this article, we will discuss the liver disorders and its implications in the practice of dentistry.
Clinical Relevance: Dentists should be able to manage/treat patients with liver disorders effectively.
Objective Statement: The reader should understand the various disorders that commonly affect the liver, oral manifestation of liver disorders and clinical implications. They should be able to make appropriate measures to prevent cross infection.
Downloads
Download data is not yet available.
References
1. Golla K, Epstein JB, and Cabay RJ; Liver disease: Current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2004;98:516-21
2. Cruz-Pamplona M, Margaix-Muñoz M, Gracia Sarrión-Pérez MG. Dental considerations in patients with liver disease. J Clin Exp Dent. 2011;3(2):e127-34.
3. Price. Update on HBV, HDV, and HEV. Top Antivir Med. 2014;21(5):157-163
4. www.who.int/features/qa/76/en
5. Little, Falace, Miller, Rhodus. Dental management of the medically comprised patient. 7th edition. Mosby Elsevier.
6. R. Monina K levels and Anne C. Moorman. Hepatitis C virus: An overview for dental health care providers. JADA 2013; 144(12):1340-1347.
7. Pol S. Hepatitis C virus: 25 years-old, the end? Med Sci (Paris). 2013 ;29(11):998- 1003.
8. Gao B and Bataller R. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology. 2011; 141(5): 1572–1585.
9. Schwenger KJ and Allard JP. Clinical approaches to non-alcoholic fatty liver disease.World J Gastroenterol. 21, 2014; 20(7): 1712–1723.
10. Scaggiante B, Kazemi M, Pozzato G, Dapas B, Farra R, Grassi M, Zanconati F, and Grassi F. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.World J Gastroenterol. 7, 2014; 20(5): 1268–1288.
11. Rodica Ghiuru, D, Munteanu. Oral manifestation of liver disease. Romanian Journal of Oral Rehabilitation.Vol. 3, No. 1, January 2011
12. Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P. Oral conditions associated with Hepatitis C virus infection. Saudi J Gastroenterol 2013;19: 245-51
13. Kumar K P M, Jois HS, Hallikerimath S, Kale AD. Oral Lichen Planus as an Extra-hepatic Manifestation of Viral Hepatitis-Evaluation in Indian Subpopulation. J Clin Diagn Res. 2013;7(9):2068-9.
14. Tsilika K, Tran A, Trucchi R, Pop S, Anty R, Cardot-N, Lacour JP, Ortonne JP, Passeron T. Secondary Hyperpigmentation During Interferon Alfa Treatment for Chronic Hepatitis C Virus Infection.JAMA Dermatol. 2013;149(6):675-677
15. Aparna Dalal and John D. Jr. Lang (2013). Anesthetic Considerations for Patients with Liver Disease, http://www.intechopen.com/books/hepatic-surgery/anesthetic-considerations-forpatients-with-liver-disease
16. www.ashm.org.au/
17. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008; 64(12):1147-61.
18. Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012. 20; 72(12):1645-69.
19. Mike Mitka, MSJ FDA Asks Physicians to Stop Prescribing HighDose Acetaminophen Products JAMA. 2014; 311(6):563.
20. www.cdc.gov/hepatitisDownloaded from www.medrech.com “The liver – an update” Halim N. & Padmashree S., Med. Res. Chron., 2016, 4 (6), 512-519
Medico Research Chronicles, 2016 519
21. Nima Mahboobi1, Stephen R Porter, Peter Karayiannis, Seyed-Moayed Alavian. Dental Treatment as a Risk Factor for Hepatitis B and C Viral Infection. A Review of the Recent Literature. J Gastrointestin Liver Dis. 2013; 22: 1: 79-86
22. Verma R, Behera B K, Jain R B, Arora V, Chayal V, Gill P S. Hepatitis C: A silent threat to the community of Haryana, India: A community-based study. AMJ 2014; 7: 1, 11-16.
23. Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, et al. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006; 124: 431–8.
24. S Setia, RS Gambhir, V Kapoor, G Jindal, S Garg, and S Setia. Attitudes and Awareness Regarding Hepatitis B and Hepatitis C Amongst Health-care Workers of a Tertiary Hospital in India. Ann Med Health Sci Res. 2013; 3(4):551–558
25. Mehta A, Gupta M, Upadhyaya N. Status of occupational hazards and their prevention among dental professionals in Chandigarh, India: A comprehensive
questionnaire survey. Dent Res J (Isfahan). 2013; 10(4):446-51.
26. Dasgupta D, Sen SK, Ghosh S, Bhattacharyya J, Goel P. Effectiveness of mouth rinses and oral prophylaxis on the reduction of microorganisms count in irreversible hydrocolloid impression: an in vivo study. J Indian Prosthodont Soc. 2013; 13(4):578-86.
27. Farhin K, Abhinav S, Thejokrishna P, Sajjad M. Stainless steel crowns reuse and decontamination techniques: A survey among Indian pediatric dentists. J Indian Soc Pedod Prev Dent 2013;31:265-9
28. Glassman P, Wong C, Gish R. A review of liver transplantation for the dentist and guidelines for dental management. Spec Care Dentist. 1993; 13(2):74-80.
2004;98:516-21
2. Cruz-Pamplona M, Margaix-Muñoz M, Gracia Sarrión-Pérez MG. Dental considerations in patients with liver disease. J Clin Exp Dent. 2011;3(2):e127-34.
3. Price. Update on HBV, HDV, and HEV. Top Antivir Med. 2014;21(5):157-163
4. www.who.int/features/qa/76/en
5. Little, Falace, Miller, Rhodus. Dental management of the medically comprised patient. 7th edition. Mosby Elsevier.
6. R. Monina K levels and Anne C. Moorman. Hepatitis C virus: An overview for dental health care providers. JADA 2013; 144(12):1340-1347.
7. Pol S. Hepatitis C virus: 25 years-old, the end? Med Sci (Paris). 2013 ;29(11):998- 1003.
8. Gao B and Bataller R. Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets. Gastroenterology. 2011; 141(5): 1572–1585.
9. Schwenger KJ and Allard JP. Clinical approaches to non-alcoholic fatty liver disease.World J Gastroenterol. 21, 2014; 20(7): 1712–1723.
10. Scaggiante B, Kazemi M, Pozzato G, Dapas B, Farra R, Grassi M, Zanconati F, and Grassi F. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.World J Gastroenterol. 7, 2014; 20(5): 1268–1288.
11. Rodica Ghiuru, D, Munteanu. Oral manifestation of liver disease. Romanian Journal of Oral Rehabilitation.Vol. 3, No. 1, January 2011
12. Alavian SM, Mahboobi N, Mahboobi N, Karayiannis P. Oral conditions associated with Hepatitis C virus infection. Saudi J Gastroenterol 2013;19: 245-51
13. Kumar K P M, Jois HS, Hallikerimath S, Kale AD. Oral Lichen Planus as an Extra-hepatic Manifestation of Viral Hepatitis-Evaluation in Indian Subpopulation. J Clin Diagn Res. 2013;7(9):2068-9.
14. Tsilika K, Tran A, Trucchi R, Pop S, Anty R, Cardot-N, Lacour JP, Ortonne JP, Passeron T. Secondary Hyperpigmentation During Interferon Alfa Treatment for Chronic Hepatitis C Virus Infection.JAMA Dermatol. 2013;149(6):675-677
15. Aparna Dalal and John D. Jr. Lang (2013). Anesthetic Considerations for Patients with Liver Disease, http://www.intechopen.com/books/hepatic-surgery/anesthetic-considerations-forpatients-with-liver-disease
16. www.ashm.org.au/
17. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008; 64(12):1147-61.
18. Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012. 20; 72(12):1645-69.
19. Mike Mitka, MSJ FDA Asks Physicians to Stop Prescribing HighDose Acetaminophen Products JAMA. 2014; 311(6):563.
20. www.cdc.gov/hepatitisDownloaded from www.medrech.com “The liver – an update” Halim N. & Padmashree S., Med. Res. Chron., 2016, 4 (6), 512-519
Medico Research Chronicles, 2016 519
21. Nima Mahboobi1, Stephen R Porter, Peter Karayiannis, Seyed-Moayed Alavian. Dental Treatment as a Risk Factor for Hepatitis B and C Viral Infection. A Review of the Recent Literature. J Gastrointestin Liver Dis. 2013; 22: 1: 79-86
22. Verma R, Behera B K, Jain R B, Arora V, Chayal V, Gill P S. Hepatitis C: A silent threat to the community of Haryana, India: A community-based study. AMJ 2014; 7: 1, 11-16.
23. Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, et al. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Indian J Med Res. 2006; 124: 431–8.
24. S Setia, RS Gambhir, V Kapoor, G Jindal, S Garg, and S Setia. Attitudes and Awareness Regarding Hepatitis B and Hepatitis C Amongst Health-care Workers of a Tertiary Hospital in India. Ann Med Health Sci Res. 2013; 3(4):551–558
25. Mehta A, Gupta M, Upadhyaya N. Status of occupational hazards and their prevention among dental professionals in Chandigarh, India: A comprehensive
questionnaire survey. Dent Res J (Isfahan). 2013; 10(4):446-51.
26. Dasgupta D, Sen SK, Ghosh S, Bhattacharyya J, Goel P. Effectiveness of mouth rinses and oral prophylaxis on the reduction of microorganisms count in irreversible hydrocolloid impression: an in vivo study. J Indian Prosthodont Soc. 2013; 13(4):578-86.
27. Farhin K, Abhinav S, Thejokrishna P, Sajjad M. Stainless steel crowns reuse and decontamination techniques: A survey among Indian pediatric dentists. J Indian Soc Pedod Prev Dent 2013;31:265-9
28. Glassman P, Wong C, Gish R. A review of liver transplantation for the dentist and guidelines for dental management. Spec Care Dentist. 1993; 13(2):74-80.
How to Cite
1.
Nilofer Halim, S Padmashree. THE LIVER – AN UPDATE. Med. res. chronicles [Internet]. 2016Dec.31 [cited 2024Apr.29];3(06):512-9. Available from: https://medrech.com/index.php/medrech/article/view/206
Section
Review Article
